GENERAL
Gland Pharma Set To Acquire Gland Pharma USA In A $5.01-Lakh Deal
Gland Pharma Ltd has approved the acquisition of 100% equity in Gland Pharma USA Inc. (Gland US), a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd., a wholly-owned subsidiary, for $5.01 lakh. Upon completion of the transaction, Gland US will become a direct wholly-owned subsidiary of Gland Pharma. The company expects to complete the […]
CW Bureau
·
Sep 13, 2026
GENERAL
Gland Pharma Signs MSA With Global Pharma Major For Sterile Injectables
Gland Pharma Ltd has entered into a strategic manufacturing and supply agreement (MSA) with a leading global pharmaceutical company for the technology transfer, manufacturing and supply of a portfolio of sterile injectable products for international markets. The agreement strengthens Gland Pharma’s position as an integrated end-to-end contract development and manufacturing organisation (CDMO), covering multiple products […]
CW Bureau
·
Aug 9, 2026
GENERAL
Gland Pharma Partners With Neuland Labs To Expand Sterile API Capacity
Gland Pharma and Neuland Laboratories have entered into a long-term strategic contract development and manufacturing organisation (CDMO) partnership to strengthen their presence in the fast-growing sterile active pharmaceutical ingredient (API) segment. As part of the collaboration, Gland Pharma will establish a dedicated sterile manufacturing suite for APIs used in microparticle depot products at its JNPC […]
CW Bureau
·
Aug 5, 2026
